Phase 1 Digestive System Neoplasm Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy
Malignant Digestive System Neoplasm
Mayo Clinic60 enrolled1 locationNCT07456852
Recruiting
Phase 1
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms
Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06026800
Recruiting
Phase 1
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms
Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06019702
Recruiting
Phase 1
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms
Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06026774